RBC cuts Regeneron stock price target to $1,045, keeps Outperform
RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...
Trade uncertainty a ‘tax on businesses’ as Bank of Canada mulls next move
Uncertainty surrounding Canada’s trade relationship with the United States is expected to cloud economic decision making by businesses and households for months, economists are warning, with the ...